Committee votes to back GSK/Ligand's Promacta
This is a discussion on Committee votes to back GSK/Ligand's Promacta within the Biotechnology News forum, part of the Industry News and Updates category; GlaxoSmithKline and Ligand Pharmaceuticals won a key endorsement for Promacta for the short-term treatment of people with chronic immune ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
06-02-2008, 04:33 PM
|
|||
|
|||
Committee votes to back GSK/Ligand's Promacta
GlaxoSmithKline and Ligand Pharmaceuticals won a key endorsement for Promacta for the short-term treatment of people with chronic immune thrombocytopenic purpura, or ITP. An FDA expert committee Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Expert panel underwhelmed by GSK's Promacta | industry_news | Biotechnology News | 0 | 05-29-2008 03:27 PM |
© 2008 DrugManagementForum™ powered by |
 |